Open AccessEfficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreal ranibizumab (Lucentis) for naive retinal vein occlusion: 1-year follow-up
Author(s) -
Alfredo Pece,
V. Isola,
Stefano Piermarocchi,
Giliola Calori
Publication year - 2010
Publication title -
british journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.016
H-Index - 153
eISSN - 1468-2079
pISSN - 0007-1161
DOI - 10.1136/bjo.2009.174060
Subject(s) - medicine , central retinal vein occlusion , branch retinal vein occlusion , ranibizumab , ophthalmology , visual acuity , fluorescein angiography , retinal , fundus photography , occlusion , surgery , bevacizumab , macular edema , chemotherapy
To evaluate the efficacy and safety of intravitreal ranibizumab (Lucentis) in patients with treatment-naive retinal vein occlusion.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom